Abstract

Chemical exposure poses significant risks to human health and the environment. Traditional methods of assessing toxicity often rely on advanced stages of disease, which can limit intervention efficacy. This research article explores the development of biomarkers for the early detection of chemical toxicity. By employing proteomic and metabolomics approaches, we aim to identify specific biological markers that reflect exposure to toxicants and the resultant biological response. This article reviews recent advancements, potential applications, and challenges in biomarker development, emphasizing the importance of timely detection for improved health outcomes.